Blog Layout

Blood clot disorder and long distance car-travel
December 2, 2020

Blood specialist, Dr. Pohan Lukito, answers frequently asked question regarding blood clot disorder and long distance car-travel.

Disclaimer: Advice given in this article is generic and may not apply to your specific situation – please consult your GP or blood specialist if you require further specific advice


Question:

I have history of blood clot in my leg many years ago, and I am about to drive up to see my family in Sydney. Do I have any risks of developing blood clots during/after travel? What can I do to minimize these risks?

Dr Pohan Lukito

Answer:

The risk of developing blood clot during long haul travel (>6 hours, can be by plane/car/train) is low. However, this risk could be increased if one has additional risk factors for blood clot; for example older age, obesity, recent surgery or immobilization, oral contraceptive pill, active cancer, smoking, strong family history and previous history of blood clot(s).

 

Blood clot develops in the legs (deep vein thrombosis) due to immobility for prolonged period during travel causing pooling of blood in the leg veins. This is often in combination with dehydration and being in high altitude (in the case of flying), however, the risk may also be applicable for long-haul car travel. In theory, short duration travels have very low risk of blood clots, and require no specific precautions.


To minimize the risks, the following recommendation is useful for most travellers:

Picturpicture from all-free-download.com


  • Drink plenty of (non alcoholic) fluid
  • Regularly moving ankles/massage calves
  • Break up the car trip by doing regular stops every few hours to stretch your legs
  • Be vigilant about the symptoms of clot in the legs or lungs – swelling/discomfort in calves, unusual shortness of breath or chest pain
  • Compression stockings can be used to reduce swelling in the legs


 For those with previous history of blood clot and additional risk factors above, but not currently on any blood thinner – it may be appropriate to consider covering themselves with low dose blood thinner such as Clexane, Xarelto and Eliquis (note: Xarelto and Eliquis use in this context is off-label). One approach is to take the low dose blood thinner starting on the day of travel for 72 hours, and then do the same thing again on travel back home, recognizing the lack of evidence in this area and low bleeding risk in taking blood thinners.


It is important to consider symptoms of blood clot even when one has returned home, as blood clot can still develop for up to 2-4 weeks following long haul travel.


Please consult your doctor/specialist if you have any of these symptoms, or more questions about this topic.


Haematologist Dr Marsali Maclean joins Ballarat Cancer Care
February 16, 2025
Haematologist Dr Marsali Maclean joins Ballarat Cancer Care
December 3, 2024
We are pleased to announce palliative care physician Dr Russell Pearce will be joining our team in February 2025.
New haematologist  joining the Ballarat Cancer Care team
August 27, 2024
We are excited to announce Dr Tishya Indran will be joining our team as of 18th September 2024. 
4th Dose COVID-19 Vaccine for Immunocompromised Patients
March 1, 2022
The Australian Technical Advisory Group on Immunisation (ATAGI) has approved a fourth dose of a COVID-19 vaccine for people with weakened immune systems. People aged 18 years or older with weakened immune system who received a 3-dose primary course of the COVID-19 vaccine are now recommended to receive the fourth dose ≥ 3 months after their third dose. This is expected to improve protection against symptomatic infection, serious illness, or death from COVID-19 infection.
COVID-19 Vaccine Booster Shots In Our Patients With Cancer
November 8, 2021
The Government and the Medical advisory group (ATAGI) have release new recommendations last week for individuals who are severely immunocompromised in regards to the COVID-19 vaccine. These recommendations will affect some (but not all) of our patients. As always, we are happy to discuss any of the recommendations further with all of our patients.
COVID-19 Vaccination FAQs July 2021
July 20, 2021
In the last few months, I have been inundated with many questions regarding COVID-19 vaccination and blood clots from patients and other health practitioners. In this article, I have compiled these frequently asked questions.
New PBS listings!
July 2, 2021
Despite a global pandemic, new data relating to oncology treatments continues to be published, and it seems that this is increasingly translating into improved drug access here in Australia.
Astra Zeneca (AZ) vaccine safety information
March 26, 2021
In light of recent reports of clotting events following Astra Zeneca (AZ) vaccine in Europe - we have been frequently asked questions regarding the safety of AZ vaccine in patients with previous clot events and/or blood problems
February 25, 2021
Two vaccines against the coronavirus have now been approved for use in Australia, role-out of the vaccine begins this week in high-risk populations.
January 18, 2021
Dr Swe Myo Htet Consultant Haematologist MBBS, FRACP, FRCPA, MRCP
More Posts
Share by: